Published in Health Risk Factor Week, February 2nd, 2010
"Non-diabetic patients with proteinuria (>1 g/day) received 50 mg of losartan daily followed by 100 mg in two treatment periods, each lasting 12 weeks. Clinical parameters and urinary TGF-beta 1 levels were measured at baseline and during the treatment period. In the whole group of patients, losartan treatment effectively decreased...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Risk Factor Week